Q1 2022 AlzChem Group AG Earnings Call Transcript
Good morning [together]. Thank you for joining us today, and welcome to our Q1 analyst call. As usual, we open with an executive summary and then move on to the figures after some strategic topics. At the end of the presentation, we will be available for questions.
So let's keep the disclaimer and go directly to page 5. Let's start with the really positive conclusion in the first quarter of 2022. Alzchem has developed very successfully in this extremely challenging environment. Above all, sales are at an all-time high. And in terms of EBITDA, we are slightly above the previous year and within the forecast corridor.
The order books are full, and incoming orders are still significantly above the previous year. At the moment, we are facing the problem that our order backlog is increasing because many orders are being held up in ports or warehouses due to the ongoing disruptions in the logistic chain.
So what has also contributed to the stable earnings development are a number of optimization projects within the Alzchem Group, which are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |